Biogen Inc. - Company & Market Research Reports

Home /
Companies /
Biogen Inc.

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

REFINE BY

KEYWORD

CATEGORIES

Central Nervous System Drugs 155
Immune Disorders Drugs 73
Genomics 73
Biopharmaceuticals 73
Biotechnology 50
Pharmaceuticals 43
Musculoskeletal Disorders Drugs 42
Oncology Drugs 41
Drug Discovery 39
Hematological Drugs 36
Biosimilars and Biosuperiors 31
Alzheimer's Disease Drugs 27
Infusions and Injectables 25
Cardiovascular Drugs 24
Allergy and Immunology 22
Clinical Trials 22
Optical Disorders Drugs 21
Mental Disorders Drugs 19
Neurology 17
Needles and Syringes 17
E-Healthcare 14
Respiratory Drugs 14
Psoriasis Drugs 14
Infectious Diseases Drugs 12
Optical 12
Pharmaceutical Manufacturing 12
Immunosuppressive Drugs 12
Healthcare Services 11
Hematology 11
Gastrointestinal Drugs 11
Drug Delivery 10
Drugs by Therapeutic Area 9
Lymphoma Drugs 9
Diagnostics 9
Endocrine and Metabolic Disorders Drugs 9
Therapeutic Area 8
Leukemia Drugs 8
Analgesics 8
Pulmonary Medicine 7
Liver and Kidney Disorders Drugs 7
Enzymes 5
Medical Devices 5
Oncology 5
Schizophrenia Drugs 5
Company Reports 4
Proteomics 4
Mental Health 4
Neurology Devices 4
Cardiology 4
Pharmaceutical Intermediates 3
Generic Drugs 3
Stem Cells 3
Hospital Management 3
Dermatology 3
Vitamins and Dietary Supplements 3
Gastroenterology 3
Dermatological Drugs 3
Urology and Nephrology 2
Pharmacoeconomics 2
Prostate Cancer Drugs 2
In Vitro Diagnostics 2
Managed Care 2
Diabetes Devices 2
Biomaterials 2
Biomarkers 2
Vaccines 2
Skin Cancer Drugs 2
Laboratory Equipment 2
Pediatrics 2
Anxiety Drugs 2
Addiction Disorders Drugs 1
Diabetes Drugs 1
Women's Health 1
Fertility Services 1
Lung Cancer Drugs 1
Colon Cancer Drugs 1
Cervical Cancer Drugs 1
Brain Cancer Drugs 1
Medical Imaging 1
Infectious Disease Testing 1
Transdermal and Transmucosal Drug Delivery 1
Contrast Media 1
Kidney Cancer Drugs 1
Nanomedicine 1
Antibiotics 1
Clinical Skills 1
Anatomy 1
Endocrinology 1
Allergy Drugs 1
Asthma Drugs 1
Sexual and Reproductive Health Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

860 Results (Page 26 of 43)
- Relevance
  Sort by

Sickle Cell Disease Treatment Market - Global Forecast 2025-2030

 Report
August 2025
184 Pages
Global

From

€3163EUR$3,545USD£2,789GBP

€3515EUR$3,939USD£3,099GBP

Regenerative Medicine Market - Forecasts from 2025 to 2030

 Report
August 2025
149 Pages
Global

From

€3524EUR$3,950USD£3,108GBP

Leukemia Treatment Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
February 2024
95 Pages
Global

From

€3500EUR$4,202USD£3,194GBP

Spinal Muscular Atrophy Treatment Market Size, Share & Trends Analysis Report By Type, By Treatment, By Route of Administration, By Region, And Segment Forecasts, 2025 - 2030

 Report
December 2024
100 Pages
Global

From

€5309EUR$5,950USD£4,681GBP

Protein 50S Ribosomal Subunit Inhibitors - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1071EUR$1,200USD£944GBP

€1338EUR$1,500USD£1,180GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Interferons Market 2025-2029

 Report
May 2025
212 Pages
Global

From

€2231EUR$2,500USD£1,967GBP

Hyper Personalized Medicines - Global Strategic Business Report

 Report
November 2025
390 Pages
Global

From

€5220EUR$5,850USD£4,603GBP

Precision Medicine - Global Strategic Business Report

 Report
November 2025
279 Pages
Global

From

€5220EUR$5,850USD£4,603GBP

Recombinant DNA Technology - Global Strategic Business Report

 Report
November 2025
212 Pages
Global

From

€5220EUR$5,850USD£4,603GBP

Personalized Medicine Market Size, Share & Trends Analysis Report By Product (Personalized Medicine Diagnostics, Personalized Medicine Therapeutics), By End Use, By Region, And Segment Forecasts, 2025 - 2033

 Report
July 2025
150 Pages
Global

From

€5309EUR$5,950USD£4,681GBP

Protein Therapeutics Market Report by Product, Therapy Area, Function, Region and Forecast 2025-2033

 Report
August 2025
122 Pages
Global

From

€2275EUR$2,549USD£2,006GBP

€2676EUR$2,999USD£2,360GBP

Pharmaceutical Market in Denmark 2025-2029

 Report
March 2025
186 Pages
Denmark

From

€2231EUR$2,500USD£1,967GBP

Crohn's Disease Therapeutics Market Forecast - Epidemiology & Pipeline Analysis

 Report
September 2022
232 Pages
Global

From

€3123EUR$3,500USD£2,754GBP

Quantum Computing in Drug Discovery Services Market: Distribution by Drug Discovery Service Offered, Therapeutic Area, and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035

 Report
February 2023
178 Pages
Global

From

€5264EUR$5,899USD£4,641GBP

Metastatic Cancer Drugs - Global Strategic Business Report

 Report
November 2025
377 Pages
Global

From

€5220EUR$5,850USD£4,603GBP

Drug Repurposing - Global Strategic Business Report

 Report
November 2025
377 Pages
Global

From

€5220EUR$5,850USD£4,603GBP

Cancer Biological Therapy - Global Strategic Business Report

 Report
November 2025
211 Pages
Global

From

€5220EUR$5,850USD£4,603GBP

Antineoplastic Agents - Global Strategic Business Report

 Report
November 2025
183 Pages
Global

From

€5220EUR$5,850USD£4,603GBP

Age-Related Macular Degeneration Market Size, Share and Trends Analysis Report by Product (Eylea, Lucentis), Disease (Wet AMD, Dry AMD), Distribution Channel, and Region 2024-2030

 Report
September 2024
100 Pages
Global

From

€5309EUR$5,950USD£4,681GBP

Company Snapshots: US Biotechnology

 Newsletter
November 2025
35 Pages
United States

From

€268EUR$300USD£236GBP

860 Results (Page 26 of 43)
- 1
- 24
- 25
- 26
- 27
- 28

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.